189 related articles for article (PubMed ID: 36433943)
41. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
[TBL] [Abstract][Full Text] [Related]
42. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
Lyon GJ; Vedaie M; Beisheim T; Park A; Marchi E; Gottlieb L; Hsieh TC; Klinkhammer H; Sandomirsky K; Cheng H; Starr LJ; Preddy I; Tseng M; Li Q; Hu Y; Wang K; Carvalho A; Martinez F; Caro-Llopis A; Gavin M; Amble K; Krawitz P; Marmorstein R; Herr-Israel E
Eur J Hum Genet; 2023 Jul; 31(7):824-833. PubMed ID: 37130971
[TBL] [Abstract][Full Text] [Related]
43. Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.
Lyon GJ; Longo J; Garcia A; Inusa F; Marchi E; Shi D; Dörfel M; Arnesen T; Aldabe R; Lyons S; Nashat MA; Bolton D
PLoS One; 2024; 19(5):e0301328. PubMed ID: 38713657
[TBL] [Abstract][Full Text] [Related]
44. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
45. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis for N-terminal acetylation by the heterodimeric NatA complex.
Liszczak G; Goldberg JM; Foyn H; Petersson EJ; Arnesen T; Marmorstein R
Nat Struct Mol Biol; 2013 Sep; 20(9):1098-105. PubMed ID: 23912279
[TBL] [Abstract][Full Text] [Related]
47. The N-terminal acetyltransferase Naa10 is essential for zebrafish development.
Ree R; Myklebust LM; Thiel P; Foyn H; Fladmark KE; Arnesen T
Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26251455
[TBL] [Abstract][Full Text] [Related]
48. Human Naa50 Protein Displays Broad Substrate Specificity for Amino-terminal Acetylation: DETAILED STRUCTURAL AND BIOCHEMICAL ANALYSIS USING TETRAPEPTIDE LIBRARY.
Reddi R; Saddanapu V; Chinthapalli DK; Sankoju P; Sripadi P; Addlagatta A
J Biol Chem; 2016 Sep; 291(39):20530-8. PubMed ID: 27484799
[TBL] [Abstract][Full Text] [Related]
49. Naa10 in development and disease.
Myklebust LM; Støve SI; Arnesen T
Oncotarget; 2015 Oct; 6(33):34041-2. PubMed ID: 26431279
[No Abstract] [Full Text] [Related]
50. Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
Saunier C; Støve SI; Popp B; Gérard B; Blenski M; AhMew N; de Bie C; Goldenberg P; Isidor B; Keren B; Leheup B; Lampert L; Mignot C; Tezcan K; Mancini GM; Nava C; Wasserstein M; Bruel AL; Thevenon J; Masurel A; Duffourd Y; Kuentz P; Huet F; Rivière JB; van Slegtenhorst M; Faivre L; Piton A; Reis A; Arnesen T; Thauvin-Robinet C; Zweier C
Hum Mutat; 2016 Aug; 37(8):755-64. PubMed ID: 27094817
[TBL] [Abstract][Full Text] [Related]
51. Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features.
Jiang Y; Guo X; Liu L; Rode S; Wang R; Liu H; Yang ZQ
Cancer Sci; 2020 May; 111(5):1829-1839. PubMed ID: 32162442
[TBL] [Abstract][Full Text] [Related]
52. Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
Bader I; McTiernan N; Darbakk C; Boltshauser E; Ree R; Ebner S; Mayr JA; Arnesen T
BMC Med Genet; 2020 Jul; 21(1):153. PubMed ID: 32698785
[TBL] [Abstract][Full Text] [Related]
53. RNA interference screen identifies NAA10 as a regulator of PXR transcription.
Oladimeji PO; Wright WC; Wu J; Chen T
Biochem Pharmacol; 2019 Feb; 160():92-109. PubMed ID: 30566892
[TBL] [Abstract][Full Text] [Related]
54. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
[TBL] [Abstract][Full Text] [Related]
55. N-α-Acetyltransferase 10 inhibits invasion and metastasis of oral squamous cell carcinoma via regulating Pirh2-p53 signalling pathway.
Wang F; Zheng J; Yang J; Luo T; Xu J; Yang Y; Gu Y; Zeng Y
J Cell Mol Med; 2022 May; 26(10):2921-2934. PubMed ID: 35366056
[TBL] [Abstract][Full Text] [Related]
56. Unc-5 homolog B (UNC5B) is one of the key downstream targets of N-α-Acetyltransferase 10 (Naa10).
Xu H; Han Y; Liu B; Li R
Sci Rep; 2016 Dec; 6():38508. PubMed ID: 27910960
[TBL] [Abstract][Full Text] [Related]
57. Structure and Mechanism of Acetylation by the N-Terminal Dual Enzyme NatA/Naa50 Complex.
Deng S; Magin RS; Wei X; Pan B; Petersson EJ; Marmorstein R
Structure; 2019 Jul; 27(7):1057-1070.e4. PubMed ID: 31155310
[TBL] [Abstract][Full Text] [Related]
58. ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.
Lee D; Jang MK; Seo JH; Ryu SH; Kim JA; Chung YH
Exp Mol Med; 2018 Jul; 50(7):1-12. PubMed ID: 30054466
[TBL] [Abstract][Full Text] [Related]
59. Autoacetylation regulates differentially the roles of ARD1 variants in tumorigenesis.
Seo JH; Park JH; Lee EJ; Vo TT; Choi H; Jang JK; Wee HJ; Ahn BJ; Cha JH; Shin MW; Kim KW
Int J Oncol; 2015 Jan; 46(1):99-106. PubMed ID: 25338643
[TBL] [Abstract][Full Text] [Related]
60. HYPK promotes the activity of the
Miklánková P; Linster E; Boyer JB; Weidenhausen J; Mueller J; Armbruster L; Lapouge K; De La Torre C; Bienvenut W; Sticht C; Mann M; Meinnel T; Sinning I; Giglione C; Hell R; Wirtz M
Sci Adv; 2022 Jun; 8(24):eabn6153. PubMed ID: 35704578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
